STOCKHOLM, Sweden, July 11, 2005 (PRIMEZONE) -- Until recently, Artelon(R) has been made in the form of fibers, scaffolds, film and granules. It can now also be made as nanostructures, fibers in the 100 nm range that is made by electrospinning.
"This is good news for people involved in tissue engineering," says Artimplant CEO Tord Lendau.
"This opens for new opportunities helping the body to heal itself. Possible applications could be wound care, reconstruction of blood vessels or to replace injured cardiac muscle tissue after an infarction. Over the long term this could result in the development of new methods for "tissue engineering," continues Tord Lendau.
"This does not imply any immediate revenues but will, in the long run, increase the use of Artelon(R). Today, none of the product development projects at Artimplant is based on this technique," Tord Lendau points out.
Artimplant's mission is to develop novel biodegradable materials and implants that meet the needs of patients, physicians and healthcare providers in orthopedics and other therapy areas. The company works together with global partners as a center of excellence in this development. Artimplant's vision is to become the partner of choice in biomaterials for hard and soft tissue repair in multiple therapy areas. Artimplant is a public company, listed on the Stockholm Exchange, O-list.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=114674&fn=wkr0001.pdf